Aalphabio logo
Aalphabio logo

Aalphabio

aalphabio.com
aalphabio.com • HQ: Seattle, United States • Venture - Series Unknown 2021 • 51-200 employees • Founded 2017 • Startup
HQ: Seattle, United States • Venture - Series Unknown 2021 • 51-200 employees • Founded 2017 • Startup
Actively hiring
Drug Discovery
Machine Learning
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$23.1M
5 rounds on record
Latest round
$20.3M
Venture round · Aug 2021 · 5 yr ago
Team
36
US Form 5500 (plan participants) · Dec 2025 · -25% in a year
Hiring now
2
open roles
Grants
$1.1M
3 grants · CORDIS
Backers
2
Xontogeny, Madrona
The money's age
Long since its last round
61 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025 Team shrank to 36 was 48 · US Form 5500 (plan participants) Aug 24, 2021 Raised a round Venture round $20.3M · SEC Form D Sep 1, 2020 Won a grant $256k · CORDIS May 1, 2020 Won a grant $620k · CORDIS Sep 13, 2019 Raised a round Venture round $2.8M · SEC Form D Jul 1, 2018 Won a grant $225k · CORDIS 2017 Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2021 $20.3M — SEC Form D
Grant Sep 2020 $256k — CORDIS
Grant May 2020 $620k — CORDIS
Venture round Sep 2019 $2.8M — SEC Form D
Grant Jul 2018 $225k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity A-Alpha Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
David YoungerExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Xontogeny accelerator Madrona fund
Investors in similar startupsfunds that back the companies most like this one
DCVC
backs Noetik, Avicenna Biosciences, Inc.
Parkwalk Advisors
backs PharmEnable
AlleyCorp
backs Nosis Biosciences
Premji Invest
backs Enveda Biosciences
Summit Partners
backs Integrated DNA Technologies
Airstreet
backs Enveda Biosciences
Similar startupsby what they do, their industry and backers
CellarityVenture round $121M · 4 yr ago • Founded 2019 • 2 roles
Cellarity is a Cambridge biotechnology company founded in 2019 that designs medicines against cell behaviour rather than a single target…
NoetikSeries A $40M · 2 yr ago • Founded 2021 • 51-200 employees • 4 roles
Noetik builds self-supervised foundation models of tumour biology trained on spatial multi-omic data it generates in its own laboratory…
Matter Works51-200 employees • 2 roles
Transforming biology from empirical to. Frontier AI lab training the first scientific poly-intelligence to read all the layers of biology…
Avicenna Biosciences, Inc.
Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate…
Nosis Biosciences11-50 employees • 2 roles
Nosis Bio delivers breakthrough receptor-targeted RNA medicines through cutting-edge physics-aware deep learning, single cell biology, and…
PharmEnableVenture round $7.5M · 3 yr ago • Founded 2018
PharmEnable combines medicinal chemistry expertise with machine learning to find drug candidates for challenging protein targets. Founded…

Visa sponsorship

  • United States · Filed H-1B visas in the last two years

Visa details by country

Overview

MEASURING, PREDICTING, ANDENGINEERING PROTEIN INTERACTIONS at Scale. A-Alpha Bio harnesses synthetic biology and machine learning to precisely engineer high-impact medicines.

Tech stack

Technologies named in job postings at Aalphabio over the last 12 months, by layer, with the share of postings for each.
Technologies in use
4
Postings analysed
3
Stack modernity
74/100
Cloud & platforms
AWS
Microsoft Entra ID
Practices & domains
Machine Learning
DNS
Sign in to see how your skills match this stack Sign In

Salary insights

Compensation ranges based on this company's open jobs
Median
$221k
Typical range
$117k – $325k
Open positions
2
2 Jobs
Middle 50%
Architect 50%
Level Jobs Median Typical range
Middle 1 $117k $117k
Architect 1 $325k $325k
Highest paying role Associate Director, Business Development $325k
Normalized to USD per year

People

David Younger
Executive Officer, Director
SEC Form D
Ben Askew
Director
SEC Form D
Randolph Lopez Barrezueta
Director
SEC Form D
Matt McIlwain
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
44/100
Stable
Open positions
2
0 opened / 1 closed in 30 days
Median time-to-fill
50 days
faster than 28% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics +100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
67% ▲
Security
33% ▼

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Seattle
Seattle United States
HQ
Seattle, WA
2 open roles 3 posted in 90 days 50-200 est. staff $221k Avg Salary
hires for Sales
seen since Aug 2026 careers board, job postings

Financials

Total raised
$24.2M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2021 $20.3M Details
Grant 2020 $256k Details
Grant 2020 $620k Details
Venture - Series Unknown 2019 $2.8M Details
Grant 2018 $225k Details